
 [
{
"symbol" : "532871",
"exchange" : "BOM",
"id": "704394",
"t" : "532871",
"e" : "BOM",
"name" : "Celestial Biolabs Limited"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:532871"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:532871"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:532871"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q4 (Dec \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "3.80%",
"annual" : "8.62%",
"ttm" : "8.49%"
},
{
"title" : "Operating margin",
"recent_quarter" : "3.82%",
"annual" : "9.55%",
"ttm" : "9.00%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "18.10%",
"ttm" : "25.75%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "3.12%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "3.43%",
"ttm" : ""
}
]
, "c" : "+0.40",
"l" : "17.80",
"cp" : "2.30",
"ccol" : "chg",
"op" : "17.35",
"hi" : "18.10",
"lo" : "17.35",
"vo" : "7,169.00",
"avvo" : "",
"hi52" : "30.40",
"lo52" : "15.00",
"mc" : "395.30M",
"pe" : "11.99",
"fwpe" : "",
"beta" : "",
"eps" : "1.48",
"dy" : "",
"ldiv" : "",
"shares" : "22.59M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "704394",
"name" : "Celestial Biolabs Limited",
"t" : "532871",
"e" : "BOM",
"l" : "17.80",
"c" : "+0.40",
"mc" : "395.30M",
"cp" : "2.30",
"ccol" : "chg"
}
,
{
"id" : "67032120554800",
"name" : "Concord Drugs Ltd",
"t" : "538965",
"e" : "BOM",
"l" : "27.10",
"c" : "-0.45",
"mc" : "210.76M",
"cp" : "-1.63",
"ccol" : "chr"
}
,
{
"id" : "2451462",
"name" : "P I Industries Ltd",
"t" : "PIIND",
"e" : "NSE",
"l" : "940.00",
"c" : "+102.45",
"mc" : "129.40B",
"cp" : "12.23",
"ccol" : "chg"
}
,
{
"id" : "3578659",
"name" : "Dr.Reddy\u0027s Laboratories Ltd",
"t" : "DRREDDY",
"e" : "NSE",
"l" : "2,193.00",
"c" : "+25.95",
"mc" : "365.16B",
"cp" : "1.20",
"ccol" : "chg"
}
,
{
"id" : "11857064",
"name" : "Gufic BioSciences Ltd",
"t" : "GUFICBIO",
"e" : "NSE",
"l" : "120.05",
"c" : "-0.75",
"mc" : "9.27B",
"cp" : "-0.62",
"ccol" : "chr"
}
,
{
"id" : "1402851",
"name" : "Alembic Pharmaceuticals Ltd",
"t" : "APLLTD",
"e" : "NSE",
"l" : "570.00",
"c" : "+8.10",
"mc" : "107.16B",
"cp" : "1.44",
"ccol" : "chg"
}
,
{
"id" : "10147154",
"name" : "Natco Pharma Ltd.",
"t" : "NATCOPHARM",
"e" : "NSE",
"l" : "775.00",
"c" : "-3.15",
"mc" : "143.19B",
"cp" : "-0.40",
"ccol" : "chr"
}
,
{
"id" : "11638775",
"name" : "Elder Pharmaceuticals Ltd",
"t" : "ELDERPHARM",
"e" : "NSE",
"l" : "38.00",
"c" : "",
"mc" : "780.40M",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "6521463",
"name" : "Parenteral Drugs (India) Ltd.",
"t" : "PDPL",
"e" : "NSE",
"l" : "18.60",
"c" : "-0.15",
"mc" : "554.58M",
"cp" : "-0.80",
"ccol" : "chr"
}
,
{
"id" : "251616120825672",
"name" : "SMS Lifesciences India Ltd",
"t" : "SMSLIFE",
"e" : "NSE",
"l" : "410.00",
"c" : "-4.55",
"mc" : "1.24B",
"cp" : "-1.10",
"ccol" : "chr"
}
,
{
"id" : "3758091",
"name" : "Ajanta Pharma Ltd",
"t" : "AJANTPHARM",
"e" : "NSE",
"l" : "1,436.00",
"c" : "+61.55",
"mc" : "126.43B",
"cp" : "4.48",
"ccol" : "chg"
}
]
, "summary" : [{
"address": "Plot No. 59 Road No. 12, Apiic Tech Park Ida Nacharam, Telangana, HYDERABAD, 500076, India",
"phone": "+91-40-23540008",
"fax": "+91-40-23542844",
"url": "http:\u002F\u002Fwww.celestialbiolabs.com\u002F",
"overview" : "Celestial Biolabs Limited is an India-based biopharmaceutical company. The Company is engaged in the production and supply of herbal and feed supplement formulations. The Company\u0027s products portfolio includes health products for men, women and children. Its product categories include herbal, enzymes and nutraceuticals. Its herbal product category includes products, such as proprietary products and classical products. Proprietary products include Biovita, Cadalmin GAe, Cel-Digest, Bioliv, Rhumacel, Cel-Clear, Biopower Gold, Bio-Dnorm, Dermacel, Gynocel, Healthone, Relifin and C-Kaps. Its Classical products include Lavan Bhaskar Churna, Talishadi Churna, Sitopaladi Churna, Sring Bhasma, Bala Chaturbhadrika Churna and Chandraprabha Vat. Its enzymes products include CELZYME-P, CELZYME-L, CELZYME-PMAX, CELZYME-DMAX, CELZYME-OXI, CELZYME-TEXDS, CELZYME-TEXWASH, CELZYME-DSB, CELZYME-Peroxide, CELZYME-RECASE, CELZYME-Phytase, CELZYME-CELCAF, CELZYME-Maxmol and CELZYME-Amyl."
} ]
, "management" : [
{
"name" : "Aditya Narayan Singh",
"age" : "59",
"title" : "Chairman of the Board, Managing Director"
}
,
{
"name" : "P. Ramakrishna",
"title" : "Compliance Officer"
}
,
{
"name" : "Jeetainder Roy Gour",
"title" : "Non Independent Non-Executive Director"
}
,
{
"name" : "Padma Singh",
"title" : "Non-Independent Non-Executive Director"
}
,
{
"name" : "B. Siva Kumar",
"age" : "67",
"title" : "Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
